Charles River Laboratories stock (US1591881009): recent earnings and outlook under the microscope

FierceBiotechTransforming neurodegenerative disease treatment

FierceBiotechAdvances and Opportunities in Dual Chamber Injectables

FierceBiotechAchieving Effective Manufacturing Scaleup for Clinical and Commercial Success

FierceBiotechUtilizing AI to Facilitate Combination Product Development

FierceBiotechEnsuring Sustainability Throughout Drug and Device Development

FierceBiotechUsing Digital Technologies to Enhance Patient Experience and Better Manage Supply Chain

Endpoints NewsCDER chief Høeg expected to leave FDA, according to source

Clinical OMICsPPG-Derived Digital Biomarker Developed for Peripheral Artery Disease Detection

Charles RiverCharles River Laboratories stock (US1591881009): recent earnings and outlook under the microscope - AD HOC NEWS

Clinical OMICsAntibody-Drug Conjugate Shows Activity in Hard-to-Treat Uterine Cancer

Clinical OMICsExchange Marketplace Launched to Help Stalled Cell and Gene Therapies

Clinical OMICsSingle Psilocybin Dose Relieves Depression for Over Three Months